Helicobacter pylori infection in functional dyspepsia

Hidekazu Suzuki, Paul Moayyedi

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Functional dyspepsia is the most common reason for patients to experience chronic epigastric pain or discomfort. The causes of functional dyspepsia are multifactorial but Helicobacter pylori infection is one likely candidate. Infection with this bacterial pathogen clearly results in chronic mucosal inflammation in the stomach and duodenum, which, in turn, might lead to abnormalities in gastroduodenal motility and sensitivity. Chronic gastritis might also affect a variety of endocrine functions of the stomach including the production of the gastrointestinal hormones and neurotransmitters somatostatin, gastrin and ghrelin. Although these abnormalities might generate symptoms in some patients with functional dyspepsia, the clinical evidence needs to be critically evaluated before this hypothesis can be confirmed. A Cochrane review reported that eradication of H. pylori in these patients had a small but statistically significant long-term effect on symptom relief when compared with placebo, lasting at least 12 months after 1 week of eradication therapy. The efficacy of eradication therapy was seen in all symptom subtypes of functional dyspepsia, but was more marked in Asian than Western patients. This evidence has led to alterations in most of the major guidelines throughout the world, which now recommend H. pylori eradication in patients with functional dyspepsia if they test positive for this bacterium.

Original languageEnglish
Pages (from-to)168-174
Number of pages7
JournalNature Reviews Gastroenterology and Hepatology
Volume10
Issue number3
DOIs
Publication statusPublished - 2013 Mar

Fingerprint

Dyspepsia
Helicobacter Infections
Helicobacter pylori
Stomach
Gastrointestinal Hormones
Ghrelin
Gastrins
Gastritis
Somatostatin
Duodenum
Bacterial Infections
Chronic Pain
Neurotransmitter Agents
Placebos
Guidelines
Inflammation
Bacteria
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Helicobacter pylori infection in functional dyspepsia. / Suzuki, Hidekazu; Moayyedi, Paul.

In: Nature Reviews Gastroenterology and Hepatology, Vol. 10, No. 3, 03.2013, p. 168-174.

Research output: Contribution to journalArticle

Suzuki, Hidekazu ; Moayyedi, Paul. / Helicobacter pylori infection in functional dyspepsia. In: Nature Reviews Gastroenterology and Hepatology. 2013 ; Vol. 10, No. 3. pp. 168-174.
@article{065659a88f5341c0abed85219c532cd4,
title = "Helicobacter pylori infection in functional dyspepsia",
abstract = "Functional dyspepsia is the most common reason for patients to experience chronic epigastric pain or discomfort. The causes of functional dyspepsia are multifactorial but Helicobacter pylori infection is one likely candidate. Infection with this bacterial pathogen clearly results in chronic mucosal inflammation in the stomach and duodenum, which, in turn, might lead to abnormalities in gastroduodenal motility and sensitivity. Chronic gastritis might also affect a variety of endocrine functions of the stomach including the production of the gastrointestinal hormones and neurotransmitters somatostatin, gastrin and ghrelin. Although these abnormalities might generate symptoms in some patients with functional dyspepsia, the clinical evidence needs to be critically evaluated before this hypothesis can be confirmed. A Cochrane review reported that eradication of H. pylori in these patients had a small but statistically significant long-term effect on symptom relief when compared with placebo, lasting at least 12 months after 1 week of eradication therapy. The efficacy of eradication therapy was seen in all symptom subtypes of functional dyspepsia, but was more marked in Asian than Western patients. This evidence has led to alterations in most of the major guidelines throughout the world, which now recommend H. pylori eradication in patients with functional dyspepsia if they test positive for this bacterium.",
author = "Hidekazu Suzuki and Paul Moayyedi",
year = "2013",
month = "3",
doi = "10.1038/nrgastro.2013.9",
language = "English",
volume = "10",
pages = "168--174",
journal = "Nature Reviews Gastroenterology and Hepatology",
issn = "1759-5045",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Helicobacter pylori infection in functional dyspepsia

AU - Suzuki, Hidekazu

AU - Moayyedi, Paul

PY - 2013/3

Y1 - 2013/3

N2 - Functional dyspepsia is the most common reason for patients to experience chronic epigastric pain or discomfort. The causes of functional dyspepsia are multifactorial but Helicobacter pylori infection is one likely candidate. Infection with this bacterial pathogen clearly results in chronic mucosal inflammation in the stomach and duodenum, which, in turn, might lead to abnormalities in gastroduodenal motility and sensitivity. Chronic gastritis might also affect a variety of endocrine functions of the stomach including the production of the gastrointestinal hormones and neurotransmitters somatostatin, gastrin and ghrelin. Although these abnormalities might generate symptoms in some patients with functional dyspepsia, the clinical evidence needs to be critically evaluated before this hypothesis can be confirmed. A Cochrane review reported that eradication of H. pylori in these patients had a small but statistically significant long-term effect on symptom relief when compared with placebo, lasting at least 12 months after 1 week of eradication therapy. The efficacy of eradication therapy was seen in all symptom subtypes of functional dyspepsia, but was more marked in Asian than Western patients. This evidence has led to alterations in most of the major guidelines throughout the world, which now recommend H. pylori eradication in patients with functional dyspepsia if they test positive for this bacterium.

AB - Functional dyspepsia is the most common reason for patients to experience chronic epigastric pain or discomfort. The causes of functional dyspepsia are multifactorial but Helicobacter pylori infection is one likely candidate. Infection with this bacterial pathogen clearly results in chronic mucosal inflammation in the stomach and duodenum, which, in turn, might lead to abnormalities in gastroduodenal motility and sensitivity. Chronic gastritis might also affect a variety of endocrine functions of the stomach including the production of the gastrointestinal hormones and neurotransmitters somatostatin, gastrin and ghrelin. Although these abnormalities might generate symptoms in some patients with functional dyspepsia, the clinical evidence needs to be critically evaluated before this hypothesis can be confirmed. A Cochrane review reported that eradication of H. pylori in these patients had a small but statistically significant long-term effect on symptom relief when compared with placebo, lasting at least 12 months after 1 week of eradication therapy. The efficacy of eradication therapy was seen in all symptom subtypes of functional dyspepsia, but was more marked in Asian than Western patients. This evidence has led to alterations in most of the major guidelines throughout the world, which now recommend H. pylori eradication in patients with functional dyspepsia if they test positive for this bacterium.

UR - http://www.scopus.com/inward/record.url?scp=84875230726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875230726&partnerID=8YFLogxK

U2 - 10.1038/nrgastro.2013.9

DO - 10.1038/nrgastro.2013.9

M3 - Article

VL - 10

SP - 168

EP - 174

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

SN - 1759-5045

IS - 3

ER -